| Niclosamide |
Influence on cell viability |
MTT Assay |
1.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
5.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
10.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
20.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
1.00 µM |
QGY-7703 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
5.00 µM |
QGY-7703 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
10.00 µM |
QGY-7703 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
20.00 µM |
QGY-7703 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
1.00 µM |
SMMC-7721 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
5.00 µM |
SMMC-7721 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
10.00 µM |
SMMC-7721 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
20.00 µM |
SMMC-7721 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT |
5.00 µM |
U266 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT |
10.00 µM |
U266 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT |
20.00 µM |
U266 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT |
30.00 µM |
U266 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT |
40.00 µM |
U266 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT |
50.00 µM |
U266 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT |
60.00 µM |
U266 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT |
70.00 µM |
U266 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT |
80.00 µM |
U266 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT |
30.00 µM |
PBMC |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT |
50.00 µM |
PBMC |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell proliferation |
MTT |
30.00 µM |
MM1.S |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell proliferation |
MTT |
50.00 µM |
MM1.S |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell proliferation |
MTT |
30.00 µM |
U266 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell proliferation |
MTT |
50.00 µM |
U266 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT |
N/A N/A |
MDA-MB-468 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT |
N/A N/A |
MCF-7 |
Homo sapiens |
|
|
|
